Donor cell | Receptor cell | Mediator | Mechanism | Effect | Ref |
---|---|---|---|---|---|
Non-small-cell lung carcinoma | TAMs | Exosomal miR-101 | CDK8 | Downregulated exosomal miR101 induces the secretion of IL1A and IL6 in macrophages and leads to inflammation in TME | [80] |
Glioma | TAMs | Exosomal miR-1246 | STAT3 and NF-κB | Promote M2-like macrophage polarization; promote tumor proliferation, migration and invasion | [81] |
Multiple myeloma | TAMs | Exosomal miR-1305 | Unknown | Promote M2-like macrophage polarization; | [82] |
Epithelial ovarian cancer | TAMs | Exosomal miR-21–3p, miR-125 b-5p and miR-181 d-5p | SOCS4/5/STAT3 | Promote M2-like macrophage polarization; promote tumor proliferation and migration | [83] |
Endometrial cancer | TAMs | Exosomal miR-21 | Unknown | Promote M2-like macrophage polarization | [84] |
TAMs | epithelial ovarian cancer | Exosomal miR-223 | PTEN-PI3K/AKT | Decrease apoptosis rate, increase cell viability, and enhance drug resistance | [85] |
Pancreatic Cancer | TAMs | Exosomal miR-301a-3p | PTEN/PI3Kγ | Promote M2-like macrophage polarization; promote pancreatic cancer cells migration, invasion, and EMT | [86] |
Glioma | TAMs | Exosomal IL-6 and miR-155-3p | IL-6-pSTAT3-miR-155-3p-autophagy-pSTAT3 | Induce autophagy and M2-like polarization in macrophage; promote tumor proliferation and migration | [87] |
Epithelial ovarian cancer | TAMs | Exosomal miR-940 | Unknown | Promote M2-like macrophage polarization; promote tumor cell proliferation and migration | [88] |
Esophageal Squamous Cell Carcinoma | TAMs | Exosomal Hsa-circ-0048117 | miR-140/TLR4 | Function as a ceRNA; promote M2-like macrophage polarization; promote tumor invasion and migration | [89] |
Hepatocellular carcinoma | TAMs | Exosomal HMMR-AS1 | miR-147a/ARID3A | Function as a ceRNA; promote M2-like macrophage polarization; promote tumor proliferation and growth | [90] |
Melanoma | TAMs | Exosomal Let-7a miRNA | Insulin-Akt-mTOR | Recruit macrophages, promote M2-like polarization and enhance mitochondrial OXPHOS in macrophage | [91] |
Non-small-cell lung cancer | TAMs | Exosome | HIF-1α | Upregulate PD-L1 in macrophage | [92] |
Breast tumor | TAMs | OSM | mTORC2-Akt1 | Promote M2-like macrophage polarization | [93] |
TAMs | Gastric cancer | CXCL8 (IL-8) | CXCR1/2-JAK/STAT1 | Deteriorate the GC malignant phenotype; promote IL-10 expression in tumor; IL-10 activates the macrophage IL-10/ NF-κB signaling pathway and induce M2 polarization | [94] |
Cervical cancer | TAMs | CCL8 | ZEB1–CCL8-CCR2–NF-κB | Enhance TAM migration | [95] |
Lung cancer | TAMs | MCP-1 (CCL2) | NF-κB/HIF-1α | Recruit macrophages | [96] |
Head and neck squamous cell carcinoma | TAMs | VEGF and IL-6 | Unknown | Recruit and polarize macrophages | [97] |
TAMs | Head and neck squamous cell carcinoma | CCL15 | CCR1-NF-κB | Promote tumor tolerance to gefitinib | [97] |
TAMs | Gastric Cancer | VEGF | PI3K-Akt and p38 MAP kinase | Promote the proliferation and invasion of cancer cell | [98] |
Lewis lung carcinomas | TAMs | Sema3A | Nrp1/VEGFR1/PlexinA1/A4 | Attract macrophages to the hypoxic region | [99] |
Hepatocellular carcinoma | TAMs | MYDGF | Unknown | Enhance macrophage chemotaxis and inflammatory cytokines release, such as IL-6 and TNF-α; enhance self-renewal of cancer stem cells; promote tumor angiogenesis | [100] |
TAMs | Breast cancer | Gal‐3 | NF-κB via ROS | Promote tumor growth, metastasis, angiogenesis; enhance VEGFA secretion and glucose consumption in macrophage | [101] |
Hepatocellular carcinoma | TAMs | HMGB1 | Unknown | Exacerbate infiltration, M2-like polarization and IL-6 expression of macrophages; promote tumor EMT | [102] |
TAMs | Breast tumor | Spint1 | HIF-2α–Spint1/HGFA HGF/c-Met | Inhibit the proliferation of tumor cell | [103] |
TAMs | Colon Cancer | SIRPα | SIRPα-CD47 | Increase macrophage phagocytic activity | [104] |
Cervical cancer | TAMs | Nrp-1 | Unknown | Recruit and polarize macrophages towards the M2 phenotype | [105] |
Hepatocellular carcinoma | TAMs | Cellular debris | TLR4/TRIF/NF-κB | Polarize macrophages into M2 type and promote the secretion of IL-1β | [106] |
TAMs | Hepatocellular carcinoma | IL-1β | IL-1β/HIF-1α/COX-2 | Enhance EMT of tumor cells | [106] |
Lewis lung carcinoma and B16-F1 melanoma | TAMs | Lactic acid | HIF-1α | Induce the expression of VEGF and the M2-like polarization of TAMs | [107] |
Lung Cancer | TAMs | Lactic acid | Unknown | Differentially affect TAM subset metabolism; trigger the T-cell suppressive capacity of TAMs | [108] |
Lung Cancer | TAMs | Succinate | SUCNR1 | Promote macrophage recruitment, migration and M2-skewed phenotype; M2 macrophages secret IL-6 to enhance cancer cell migration; induce cancer cell migration and EMT | [109] |